Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management

Seminars in Respiratory and Critical Care Medicine

Volumn 36, Issue 4, 2015, Pages 575-591

  Putcha, Nirupama ^a   Drummond, M Bradley ^a   Wise, Robert A ^a   Hansel, Nadia N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical outcomes; comorbidity; COPD

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC DISEASE; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HEALTH STATUS; HOSPITALIZATION; HUMAN; IRON THERAPY; LUNG CANCER; METABOLIC SYNDROME X; MORTALITY; NEUROLOGIC DISEASE; OBESITY; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; CHRONIC DISEASE; DISEASE COURSE; DISEASE MANAGEMENT; EXERCISE TOLERANCE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTOR;

CHRONIC DISEASE; COMORBIDITY; DISEASE MANAGEMENT; DISEASE PROGRESSION; EXERCISE TOLERANCE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS;

EID: 84938504757     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0035-1556063     Document Type: Article

References (218)

1. Almagro P., López García F., Cabrera F., et al. Grupo Epoc De La Sociedad Española De Medicina Interna. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med: 2010; 104 2 253 259
2. Anecchino C., Rossi E., Fanizza C., De Rosa M., Tognoni G., Romero M.; working group ARNO project. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis: 2007; 2 4 567 574
3. Areias V., Carreira S., Anciães M., Pinto P., Bárbara C. Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease. Rev Port Pneumol: 2014; 20 1 5 11
4. Fumagalli G., Fabiani F., Forte S., et al. INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units. Multidiscip Respir Med: 2013; 8 1 28
5. Putcha N., Puhan M. A., Hansel N. N., Drummond M. B., Boyd C. M. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD: 2013; 10 3 324 332
6. García-Olmos L., Alberquilla A., Ayala V., et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract: 2013; 14 11
7. López Varela M. V., Montes de Oca M., Halbert R., et al. PLATINO team. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol: 2013; 49 11 468 474
8. Noteboom B., Jenkins S., Maiorana A., Cecins N., Ng C., Hill K. Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation. J Cardiopulm Rehabil Prev: 2014; 34 1 75 79
9. Vanfleteren L. E., Spruit M. A., Groenen M., et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2013; 187 7 728 735
10. Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis: 1987; 40 5 373 383
11. Divo M., Cote C., de Torres J. P., et al. BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2012; 186 2 155 161
12. de Torres J. P., Casanova C., Marín J. M., et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax: 2014; 69 9 799 804
13. Frei A., Muggensturm P., Putcha N., et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol: 2014; 67 8 904 911
14. Garcia-Aymerich J., Gómez F. P., Benet M., et al. PAC-COPD Study Group. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax: 2011; 66 5 430 437
15. Baty F., Putora P. M., Isenring B., Blum T., Brutsche M. Comorbidities and burden of COPD: a population based case-control study. PLoS ONE: 2013; 8 5 e63285
16. Thomsen M., Dahl M., Lange P., Vestbo J., Nordestgaard B. G. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2012; 186 10 982 988
17. Almagro P., Cabrera F. J., Diez J., et al. Working Group on COPD, Spanish Society of Internal Medicine. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de Medicina Interna (ESMI) study. Chest: 2012; 142 5 1126 1133
18. Kinnunen T., Säynäjäkangas O., Tuuponen T., Keistinen T. Impact of comorbidities on the duration of COPD patients' hospital episodes. Respir Med: 2003; 97 2 143 146
19. Lin P. J., Shaya F. T., Scharf S. M. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med: 2010; 104 5 697 704
20. Budweiser S., Harlacher M., Pfeifer M., Jörres R. A. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. COPD: 2014; 11 4 388 400
21. Marti S., Muñoz X., Rios J., Morell F., Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J: 2006; 27 4 689 696
22. Miller J., Edwards L. D., Agustí A., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med: 2013; 107 9 1376 1384
23. Koskela J., Kilpeläinen M., Kupiainen H., et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med: 2014; 14 102
24. Putcha N., Han M. K., Martinez C. H., et al. the COPDGene® Investigators. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis (Miami): 2014; 1 1 105 114
25. Ekström M. P., Jogréus C., Ström K. E. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS ONE: 2012; 7 4 e35806
26. Singh B., Mielke M. M., Parsaik A. K., et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol: 2014; 71 5 581 588
27. Incalzi R. A., Chiappini F., Fuso L., Torrice M. P., Gemma A., Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med: 1998; 92 3 527 533
28. Dodd J. W., Charlton R. A., van den Broek M. D., Jones P. W. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest: 2013; 144 1 119 127
29. (GOLD) GIfCOLd. Global Strategy for Diagnosis, Management, and Prevention of COPD. Available at: http://www.goldcopd.org/.2014
30. Tulek B., Atalay N. B., Yildirim G., Kanat F., Süerdem M. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology: 2014; 19 6 873 880
31. Filipowski M., Bozek A., Kozlowska R., Czyżewski D., Jarzab J. The influence of hospitalizations due to exacerbations or spontaneous pneumothoraxes on the quality of life, mental function and symptoms of depression and anxiety in patients with COPD or asthma. J Asthma: 2014; 51 3 294 298
32. Dodd J. W., Chung A. W., van den Broek M. D., Barrick T. R., Charlton R. A., Jones P. W. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med: 2012; 186 3 240 245
33. Lahousse L., Vernooij M. W., Darweesh S. K., et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am J Respir Crit Care Med: 2013; 188 7 783 788
34. Li C. H., Chen W. C., Liao W. C., et al. The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study. QJM: 2015; 108 1 39 45
35. Light R. W., Merrill E. J., Despars J. A., Gordon G. H., Mutalipassi L. R. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest: 1985; 87 1 35 38
36. Al-shair K., Dockry R., Mallia-Milanes B., Kolsum U., Singh D., Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med: 2009; 103 10 1572 1579
37. Di Marco F., Verga M., Reggente M., et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med: 2006; 100 10 1767 1774
38. Janssen D. J., Spruit M. A., Leue C., et al. Ciro Network. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis: 2010; 7 3 147 157
39. Jennings J. H., Digiovine B., Obeid D., Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung: 2009; 187 2 128 135
40. Kim K. U., Park H. K., Jung H. Y., et al. Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung: 2014; 192 2 243 249
41. Qian J., Simoni-Wastila L., Langenberg P., et al. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc: 2013; 61 5 754 761
42. van Manen J. G., Bindels P. J., Dekker F. W., IJzermans C. J., van der Zee J. S., Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax: 2002; 57 5 412 416
43. Omachi T. A., Katz P. P., Yelin E. H., et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med: 2009; 122 8 778.e9 778.e15
44. Ng T. P., Niti M., Fones C., Yap K. B., Tan W. C. Co-morbid association of depression and COPD: a population-based study. Respir Med: 2009; 103 6 895 901
45. Ohayon M. M. Chronic Obstructive Pulmonary Disease and its association with sleep and mental disorders in the general population. J Psychiatr Res: 2014; 54 79 84
46. van den Bemt L., Schermer T., Bor H., et al. The risk for depression comorbidity in patients with COPD. Chest: 2009; 135 1 108 114
47. Atlantis E., Fahey P., Cochrane B., Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest: 2013; 144 3 766 777
48. Qian J., Simoni-Wastila L., Rattinger G. B., et al. Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD. Gen Hosp Psychiatry: 2013; 35 6 612 618
49. Lou P., Chen P., Zhang P., et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care: 2014; 59 1 54 61
50. Stage K. B., Middelboe T., Pisinger C. Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand: 2005; 111 4 320 323
51. von Leupoldt A., Taube K., Lehmann K., Fritzsche A., Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest: 2011; 140 3 730 736
52. Gudmundsson G., Gislason T., Janson C., et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med: 2006; 100 1 87 93
53. Hynninen M. J., Pallesen S., Nordhus I. H. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis: 2007; 2 3 323 328
54. Quint J. K., Baghai-Ravary R., Donaldson G. C., Wedzicha J. A. Relationship between depression and exacerbations in COPD. Eur Respir J: 2008; 32 1 53 60
55. Hilmarsen C. W., Wilke S., Engan H., et al. Impact of symptoms of anxiety and depression on COPD Assessment Test scores. Eur Respir J: 2014; 43 3 898 900
56. Gudmundsson G., Gislason T., Janson C., et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J: 2005; 26 3 414 419
57. Al-shair K., Kolsum U., Dockry R., Morris J., Singh D., Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res: 2011; 12 3
58. Janssen D. J., Müllerova H., Agusti A., et al. Eclipse Investigators. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med: 2014; 108 11 1647 1654
59. Dinicola G., Julian L., Gregorich S. E., Blanc P. D., Katz P. P. The role of social support in anxiety for persons with COPD. J Psychosom Res: 2013; 74 2 110 115
60. Jordan N., Lee T. A., Valenstein M., Weiss K. B. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med: 2007; 22 10 1447 1452
61. Pooler A., Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis: 2014; 9 315 330
62. Eiser N., Harte R., Spiros K., Phillips C., Isaac M. T. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD: 2005; 2 2 233 241
63. Tselebis A., Bratis D., Pachi A., et al. A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med: 2013; 8 1 41
64. Paz-Díaz H., Montes de Oca M., López J. M., Celli B. R. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil: 2007; 86 1 30 36
65. Garuti G., Cilione C., Dell'Orso D., et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis: 2003; 59 1 56 61
66. Franco C. B., Paz-Filho G., Gomes P. E., et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int: 2009; 20 11 1881 1887
67. Heerema-Poelman A., Stuive I., Wempe J. B. Adherence to a maintenance exercise program 1year after pulmonary rehabilitation: what are the predictors of dropout? J Cardiopulm Rehabil Prev: 2013; 33 6 419 426
68. Silverberg D. S., Mor R., Weu M. T., Schwartz D., Schwartz I. F., Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med: 2014; 14 24
69. Krishnan G., Grant B. J., Muti P. C., et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med: 2006; 6 23
70. Chambellan A., Chailleux E., Similowski T.; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest: 2005; 128 3 1201 1208
71. Boutou A. K., Karrar S., Hopkinson N. S., Polkey M. I. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration: 2013; 85 2 126 131
72. Haja Mydin H., Murphy S., Clague H., Sridharan K., Taylor I. K. Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis: 2013; 8 151 157
73. Rasmussen L., Christensen S., Lenler-Petersen P., Johnsen S. P. Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol: 2011; 3 1 5
74. Martinez-Rivera C., Portillo K., Muñoz-Ferrer A., et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD: 2012; 9 3 243 250
75. Nguyen H. Q., Chu L., Amy Liu I. L., et al. Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc: 2014; 11 5 695 705
76. Barba R., de Casasola G. G., Marco J., et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin: 2012; 28 4 617 622
77. Copur A. S., Fulambarker A., Molnar J., et al. Role of Anemia in Home Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients. Am J Ther: 2013
78. Boutou A. K., Stanopoulos I., Pitsiou G. G., et al. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration: 2011; 82 3 237 245
79. Ali Zohal M., Yazdi Z., Kazemifar A. M. Daytime sleepiness and quality of sleep in patients with COPD compared to control group. Glob J Health Sci: 2013; 5 3 150 155
80. Zohal M. A., Yazdi Z., Kazemifar A. M., Mahjoob P., Ziaeeha M. Sleep Quality and Quality of Life in COPD Patients with and without Suspected Obstructive Sleep Apnea. Sleep Disord: 2014; 2014 508372
81. Krieger A. C., Patel N., Green D., et al. Respiratory disturbance during sleep in COPD patients without daytime hypoxemia. Int J Chron Obstruct Pulmon Dis: 2007; 2 4 609 615
82. Bednarek M., Plywaczewski R., Jonczak L., Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration: 2005; 72 2 142 149
83. Sanders M. H., Newman A. B., Haggerty C. L., et al. Sleep Heart Health Study. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med: 2003; 167 1 7 14
84. Rizzi M., Palma P., Andreoli A., et al. Prevalence and clinical feature of the overlap syndrome, obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep Breath: 1997; 2 3 68 72
85. Chaouat A., Weitzenblum E., Krieger J., Ifoundza T., Oswald M., Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med: 1995; 151 1 82 86
86. Turcani P., Skrickova J., Pavlik T., Janousova E., Orban M. The prevalence of obstructive sleep apnea in patients hospitalized for COPD exacerbation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub: 2014;. doi: 10.5507/bp.2014.002 [e-pub ahead of print]
87. Marin J. M., Soriano J. B., Carrizo S. J., Boldova A., Celli B. R. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med: 2010; 182 3 325 331
88. Shaya F. T., Lin P. J., Aljawadi M. H., Scharf S. M. Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep Breath: 2009; 13 4 317 323
89. Ganga H. V., Nair S. U., Puppala V. K., Miller W. L. Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study. J Geriatr Cardiol: 2013; 10 2 129 134
90. Shiina K., Tomiyama H., Takata Y., et al. Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respir Med: 2012; 106 9 1335 1341
91. Sharma B., Neilan T. G., Kwong R. Y., et al. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD: 2013; 10 1 4 10
92. McNicholas W. T. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med: 2009; 180 8 692 700
93. Ogden C. L., Carroll M. D., Kit B. K., Flegal K. M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA: 2014; 311 8 806 814
94. Dimov D., Tacheva T., Koychev A., Ilieva V., Prakova G., Vlaykova T. Obesity in Bulgarian patients with chronic obstructive pulmonary disease. Chron Respir Dis: 2013; 10 4 215 222
95. Rodríguez D. A., Garcia-Aymerich J., Valera J. L., et al. PAC-COPD Study Group. Determinants of exercise capacity in obese and non-obese COPD patients. Respir Med: 2014; 108 5 745 751
96. García-Rio F., Soriano J. B., Miravitlles M., et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS ONE: 2014; 9 8 e105220
97. Cecere L. M., Littman A. J., Slatore C. G., et al. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD: 2011; 8 4 275 284
98. Vozoris N. T., O'Donnell D. E. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J: 2012; 19 3 e18 e24
99. Aiello M., Teopompi E., Tzani P., et al. Maximal exercise in obese patients with COPD: the role of fat free mass. BMC Pulm Med: 2014; 14 96
100. Bautista J., Ehsan M., Normandin E., Zuwallack R., Lahiri B. Physiologic responses during the six minute walk test in obese and non-obese COPD patients. Respir Med: 2011; 105 8 1189 1194
101. Laviolette L., Sava F., O'Donnell D. E., et al. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med: 2010; 10 33
102. Ora J., Laveneziana P., Ofir D., Deesomchok A., Webb K. A., O'Donnell D. E. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med: 2009; 180 10 964 971
103. O'Donnell D. E., Deesomchok A., Lam Y. M., et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest: 2011; 140 2 461 468
104. Boiselle P. M., Litmanovich D. E., Michaud G., et al. Dynamic expiratory tracheal collapse in morbidly obese COPD patients. COPD: 2013; 10 5 604 610
105. Breyer M. K., Spruit M. A., Celis A. P., Rutten E. P., Janssen P. P., Wouters E. F.; CIRO Network. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Clin Nutr: 2009; 28 6 642 647
106. Bridevaux P. O., Gerbase M. W., Schindler C., et al. Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2. Eur Respir J: 2009; 34 2 332 339
107. Poulain M., Doucet M., Drapeau V., et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis: 2008; 5 1 35 41
108. Stanciu S., Iordache M., Busuioceanu A., et al. The metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Rom J Intern Med: 2009; 47 2 123 132
109. Barbarito N., De Mattia E. Grading the severity of obstruction in patients with chronic obstructive pulmonary disease and morbid obesity. Monaldi Arch Chest Dis: 2013; 79 3-4 121 127
110. Collins B. F., Feemster L. C., Rinne S. T., Au D. H. Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest: 2015; 147 2 369 376
111. Minas M., Kostikas K., Papaioannou A. I., et al. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD: 2011; 8 6 414 420
112. Park B. H., Park M. S., Chang J., et al. Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea. Int J Tuberc Lung Dis: 2012; 16 5 694 700
113. Akplnar E. E., Akplnar S., Ertek S., Sayln E., Gülhan M. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks: 2012; 60 3 230 237
114. Marquis K., Maltais F., Duguay V., et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil: 2005; 25 4 226 232, discussion 233-234
115. Park S. K., Larson J. L. The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease. J Cardiovasc Nurs: 2014; 29 6 499 507
116. Breyer M. K., Spruit M. A., Hanson C. K., et al. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS ONE: 2014; 9 6 e98013
117. Ozgen Alpaydin A., Konyar Arslan I., Serter S., et al. Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease. Multidiscip Respir Med: 2013; 8 1 61
118. Díez-Manglano J., Barquero-Romero J., Almagro P., et al. Working Group on COPD; Spanish Society of Internal Medicine. COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med: 2014; 9 4 419 425
119. Watz H., Waschki B., Kirsten A., et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest: 2009; 136 4 1039 1046
120. Chung J. H., Hwang H. J., Han C. H., Son B. S., Kim D. H., Park M. S. Association between sarcopenia and metabolic syndrome in chronic obstructive pulmonary disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD: 2015; 12 1 82 89
121. Fritzsche A., Watz H., Magnussen H., Tuinmann G., Löwe B., von Leupoldt A. Cognitive biases in patients with chronic obstructive pulmonary disease and depression - a pilot study. Br J Health Psychol: 2013; 18 4 827 843
122. Küpeli E., Ulubay G., Ulasli S. S., Sahin T., Erayman Z., Gürsoy A. Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Endocrine: 2010; 38 1 76 82
123. Leone N., Courbon D., Thomas F., et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med: 2009; 179 6 509 516
124. Stanciu S., Marinescu R., Iordache M., Dumitrescu S., Mure͆an M., Bogdan M. A. Are systemic inflammatory profiles different in patients with COPD and metabolic syndrome as compared to those with COPD alone? Rom J Intern Med: 2009; 47 4 381 386
125. Vanfleteren L. E., van Meerendonk A. M., Franssen F. M., et al. A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study. Respir Med: 2014; 108 6 883 890
126. Mannino D. M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J: 2008; 32 4 962 969
127. Rogliani P., Calzetta L., Segreti A., Barrile A., Cazzola M. Diabetes mellitus among outpatients with COPD attending a university hospital. Acta Diabetol: 2014; 51 6 933 940
128. Lee C. T., Mao I. C., Lin C. H., Lin S. H., Hsieh M. C. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study. Eur J Clin Invest: 2013; 43 11 1113 1119
129. Rana J. S., Mittleman M. A., Sheikh J., et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care: 2004; 27 10 2478 2484
130. Parappil A., Depczynski B., Collett P., Marks G. B. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology: 2010; 15 6 918 922
131. Sandler M., Bunn A. E., Stewart R. I. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis: 1987; 135 1 223 229
132. Klein O. L., Meltzer D., Carnethon M., Krishnan J. A. Type II diabetes mellitus is associated with decreased measures of lung function in a clinical setting. Respir Med: 2011; 105 7 1095 1098
133. Kinney G. L., Black-Shinn J. L., Wan E. S., et al. COPDGene Investigators. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care: 2014; 37 2 389 395
134. Suissa S., Kezouh A., Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med: 2010; 123 11 1001 1006
135. O'Byrne P. M., Rennard S., Gerstein H., et al. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir Med: 2012; 106 11 1487 1493
136. Bolton C. E., Evans M., Ionescu A. A., et al. Insulin resistance and inflammation - a further systemic complication of COPD. COPD: 2007; 4 2 121 126
137. Cazzola M., Calzetta L., Bettoncelli G., et al. Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study. Respir Med: 2012; 106 2 249 256
138. Curkendall S. M., DeLuise C., Jones J. K., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol: 2006; 16 1 63 70
139. de Miguel-Díez J., Carrasco-Garrido P., Rejas-Gutierrez J., et al. The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord: 2010; 10 8
140. Feary J. R., Rodrigues L. C., Smith C. J., Hubbard R. B., Gibson J. E. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax: 2010; 65 11 956 962
141. Huiart L., Ernst P., Suissa S. Cardiovascular morbidity and mortality in COPD. Chest: 2005; 128 4 2640 2646
142. Mapel D. W., Dedrick D., Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD: 2005; 2 1 35 41
143. Mapel D. W., Hurley J. S., Frost F. J., Petersen H. V., Picchi M. A., Coultas D. B. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med: 2000; 160 17 2653 2658
144. Müllerova H., Agusti A., Erqou S., Mapel D. W. Cardiovascular comorbidity in COPD: systematic literature review. Chest: 2013; 144 4 1163 1178
145. McGarvey L. P., John M., Anderson J. A., Zvarich M., Wise R. A.; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax: 2007; 62 5 411 415
146. Zielinski J., MacNee W., Wedzicha J., et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis: 1997; 52 1 43 47
147. Mannino D. M., Doherty D. E., Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med: 2006; 100 1 115 122
148. Campo G., Guastaroba P., Marzocchi A., et al. Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest: 2013; 144 3 750 757
149. Konecny T., Somers K., Orban M., et al. Interactions between COPD and outcomes after percutaneous coronary intervention. Chest: 2010; 138 3 621 627
150. Sidney S., Sorel M., Quesenberry C. P. Jr, DeLuise C., Lanes S., Eisner M. D. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest: 2005; 128 4 2068 2075
151. Black-Shinn J. L., Kinney G. L., Wise A. L., et al. COPDGene Investigators. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD: 2014; 11 5 546 551
152. Patel A. R., Donaldson G. C., Mackay A. J., Wedzicha J. A., Hurst J. R. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest: 2012; 141 4 851 857
153. Dalal A. A., Shah M., Lunacsek O., Hanania N. A. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med: 2011; 105 10 1516 1522
154. Gale N. S., Duckers J. M., Enright S., Cockcroft J. R., Shale D. J., Bolton C. E. Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulm Med: 2011; 11 20
155. Bor S., Kitapcioglu G., Solak Z. A., Ertilav M., Erdinc M. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. J Gastroenterol Hepatol: 2010; 25 2 309 313
156. García Rodríguez L. A., Ruigómez A., Martín-Merino E., Johansson S., Wallander M. A. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest: 2008; 134 6 1223 1230
157. Kim J., Lee J. H., Kim Y., et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med: 2013; 13 51
158. Mokhlesi B., Morris A. L., Huang C. F., Curcio A. J., Barrett T. A., Kamp D. W. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest: 2001; 119 4 1043 1048
159. Rascon-Aguilar I. E., Pamer M., Wludyka P., et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest: 2006; 130 4 1096 1101
160. Casanova C., Baudet J. S., del Valle Velasco M., et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J: 2004; 23 6 841 845
161. Kamble N. L., Khan N. A., Kumar N., Nayak H. K., Daga M. K. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology: 2013; 18 3 463 467
162. Lee A. L., Button B. M., Denehy L., et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology: 2014; 19 2 211 217
163. Kempainen R. R., Savik K., Whelan T. P., Dunitz J. M., Herrington C. S., Billings J. L. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest: 2007; 131 6 1666 1671
164. Orr W. C., Shamma-Othman Z., Allen M., Robinson M. G. Esophageal function and gastroesophageal reflux during sleep and waking in patients with chronic obstructive pulmonary disease. Chest: 1992; 101 6 1521 1525
165. Liang B. M., Feng Y. L. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung: 2012; 190 3 277 282
166. Rascon-Aguilar I. E., Pamer M., Wludyka P., Cury J., Vega K. J. Poorly treated or unrecognized GERD reduces quality of life in patients with COPD. Dig Dis Sci: 2011; 56 7 1976 1980
167. Martinez C. H., Okajima Y., Murray S., et al. COPDGene Investigators. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res: 2014; 15 62
168. Ajmera M., Raval A. D., Shen C., Sambamoorthi U. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis: 2014; 9 339 348
169. Sakae T. M., Pizzichini M. M., Teixeira P. J., Silva R. M., Trevisol D. J., Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol: 2013; 39 3 259 271
170. Takada K., Matsumoto S., Kojima E., et al. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med: 2011; 105 10 1531 1536
171. Terada K., Muro S., Sato S., et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax: 2008; 63 11 951 955
172. Sasaki T., Nakayama K., Yasuda H., et al. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc: 2009; 57 8 1453 1457
173. Boeree M. J., Peters F. T., Postma D. S., Kleibeuker J. H. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J: 1998; 11 5 1070 1074
174. Bhattacharyya P., Paul R., Ghosh M., et al. Prevalence of osteoporosis and osteopenia in advanced chronic obstructive pulmonary disease patients. Lung India: 2011; 28 3 184 186
175. Bolton C. E., Stone M. D., Edwards P. H., Duckers J. M., Evans W. D., Shale D. J. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease. Chron Respir Dis: 2009; 6 2 81 87
176. Ferguson G. T., Calverley P. M., Anderson J. A., et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest: 2009; 136 6 1456 1465
177. Graat-Verboom L., Spruit M. A., van den Borne B. E., et al. CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med: 2009; 103 8 1143 1151
178. Hattiholi J., Gaude G. S. Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lung India: 2014; 31 3 221 227
179. Jorgensen N. R., Schwarz P., Holme I., Henriksen B. M., Petersen L. J., Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med: 2007; 101 1 177 185
180. Ogura-Tomomatsu H., Asano K., Tomomatsu K., et al. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD: 2012; 9 4 332 337
181. Incalzi R. A., Caradonna P., Ranieri P., et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med: 2000; 94 11 1079 1084
182. Graat-Verboom L., Smeenk F. W., van den Borne B. E., et al. Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone: 2012; 50 6 1234 1239
183. Silva D. R., Coelho A. C., Dumke A., et al. Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care: 2011; 56 7 961 968
184. Kiyokawa H., Muro S., Oguma T., et al. Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD: 2012; 9 3 235 242
185. Sabit R., Bolton C. E., Edwards P. H., et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2007; 175 12 1259 1265
186. Fattahi F., ten Hacken N. H., Löfdahl C. G., et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir Res: 2013; 14 10
187. Jamieson D. B., Matsui E. C., Belli A., et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2013; 188 2 187 192
188. Caillaud D., Chanez P., Escamilla R., et al. Initiatives BPCO Scientific Committee and Investigators. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease. Respirology: 2014; 19 3 346 352
189. Drummond M. B., Kirk G. D. HIV-associated obstructive lung diseases: insights and implications for the clinician. Lancet Respir Med: 2014; 2 7 583 592
190. Diaz P. T., Clanton T. L., Pacht E. R. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med: 1992; 116 2 124 128
191. Mitchell D. M., Fleming J., Pinching A. J., et al. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis: 1992; 146 3 745 751
192. Petrache I., Diab K., Knox K. S., et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax: 2008; 63 5 463 469
193. Crothers K., Butt A. A., Gibert C. L., Rodriguez-Barradas M. C., Crystal S., Justice A. C.; Veterans Aging Cohort 5 Project Team. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest: 2006; 130 5 1326 1333
194. Crothers K., Huang L., Goulet J. L., et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med: 2011; 183 3 388 395
195. Gingo M. R., Balasubramani G. K., Kingsley L., et al. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS ONE: 2013; 8 3 e58812
196. Madeddu G., Fois A. G., Calia G. M., et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection: 2013; 41 2 347 353
197. Drummond M. B., Kirk G. D., Astemborski J., et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax: 2012; 67 4 309 314
198. Drummond M. B., Merlo C. A., Astemborski J., et al. The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS: 2013; 27 8 1303 1311
199. Drummond M. B., Kirk G. D., McCormack M. C., et al. HIV and COPD: impact of risk behaviors and diseases on quality of life. Qual Life Res: 2010; 19 9 1295 1302
200. Sigel K., Wisnivesky J., Gordon K., et al. HIV as an independent risk factor for incident lung cancer. AIDS: 2012; 26 8 1017 1025
201. Kirk G. D., Merlo C., O' Driscoll P., et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis: 2007; 45 1 103 110
202. Lambert A. A., Merlo C. A., Kirk G. D. Human immunodeficiency virus-associated lung malignancies. Clin Chest Med: 2013; 34 2 255 272
203. Kaviani N., Bukberg P., Manessis A., Yen V., Young I. Iatrogenic osteoporosis, bilateral HIP osteonecrosis, and secondary adrenal suppression in an HIV-infected man receiving inhaled corticosteroids and ritonavir-boosted highly active antiretroviral therapy. Endocr Pract: 2011; 17 1 74 78
204. Mahlab-Guri K., Asher I., Gradstein S., et al. Inhaled fluticasone causes iatrogenic Cushing's syndrome in patients treated with Ritonavir. J Asthma: 2011; 48 8 860 863
205. de Torres J. P., Bastarrika G., Wisnivesky J. P., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest: 2007; 132 6 1932 1938
206. Mannino D. M., Aguayo S. M., Petty T. L., Redd S. C. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med: 2003; 163 12 1475 1480
207. Turner M. C., Chen Y., Krewski D., Calle E. E., Thun M. J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med: 2007; 176 3 285 290
208. Wilson D. O., Weissfeld J. L., Balkan A., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med: 2008; 178 7 738 744
209. Young R. P., Hopkins R. J., Christmas T., Black P. N., Metcalf P., Gamble G. D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J: 2009; 34 2 380 386
210. Anthonisen N. R., Skeans M. A., Wise R. A., Manfreda J., Kanner R. E., Connett J. E.; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med: 2005; 142 4 233 239
211. Ueda K., Jinbo M., Li T. S., Yagi T., Suga K., Hamano K. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res: 2006; 12 22 6730 6736
212. Sekine Y., Yamada Y., Chiyo M., et al. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg: 2007; 84 3 946 950
213. Wauters E., Smeets D., Coolen J., et al. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J: 2011; 38 4 924 931
214. Young R. P., Whittington C. F., Hopkins R. J., et al. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J: 2010; 36 6 1375 1382
215. Schembri F., Sridhar S., Perdomo C., et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A: 2009; 106 7 2319 2324
216. Rooney C., Sethi T. The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration: 2011; 81 2 89 104
217. de-Torres J. P., Casanova C., Marín J. M., et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study. Respir Med: 2013; 107 5 702 707
218. Mapel D. Insights into COPD comorbidities from the OLIN study and other large databases. COPD: 2011; 8 6 397 399